We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WX
626
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $366K | 0.01% |
+8,471
| New | +$357K |
|
627
Applied Materials
AMAT
$403B
| $364K | 0.01% |
24,800
-322,342
| -93% | -$5.39M |
|
|
SNBR
628
DELISTED
Sleep Number
SNBR
| $364K | 0.01% |
16,623
+8,078
| +95% | +$206K |
|
|
HIBB
629
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $363K | 0.01% |
10,375
+4,348
| +72% | +$181K |
|
630
OGE Energy
OGE
$9.78B
| $358K | ﹤0.01% |
+13,095
| New | +$373K |
|
|
DCOM
631
DELISTED
Dime Community Bancshares
DCOM
| $355K | ﹤0.01% |
21,055
| – | – |
|
632
Groupon
GRPN
$1.05B
| $354K | ﹤0.01% |
5,434
-10,249
| -65% | -$912K |
|
|
NPD
633
DELISTED
CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM
NPD
| $354K | ﹤0.01% |
+165,969
| New | +$364K |
|
634
CALL
Wayfair
W
$11.2B
| $351K | ﹤0.01% |
+10,000
| New | +$384K |
|
|
MDP
635
DELISTED
Meredith Corporation
MDP
| $350K | ﹤0.01% |
+8,224
| New | +$392K |
|
636
Crown Holdings
CCK
$12.8B
| $349K | ﹤0.01% |
7,631
-76,925
| -91% | -$3.89M |
|
|
ANDV
637
DELISTED
Andeavor
ANDV
| $349K | ﹤0.01% |
+3,591
| New | +$349K |
|
|
CIT
638
DELISTED
CIT Group Inc.
CIT
| $347K | ﹤0.01% |
+8,665
| New | +$389K |
|
639
Old Dominion Freight Line
ODFL
$44.1B
| $346K | ﹤0.01% |
+17,001
| New | +$386K |
|
640
Teladoc Health
TDOC
$1.22B
| $345K | ﹤0.01% |
+15,474
| New | +$418K |
|
641
CenterPoint Energy
CNP
$27.7B
| $344K | ﹤0.01% |
19,075
+1,194
| +7% | +$22.3K |
|
642
Expedia Group
EXPE
$35.4B
| $343K | ﹤0.01% |
2,917
+975
| +50% | +$112K |
|
643
Mondelez International
MDLZ
$79.5B
| $343K | ﹤0.01% |
8,200
-3,873
| -32% | -$167K |
|
|
MRSH
644
Marsh
MRSH
$90.5B
| $342K | ﹤0.01% |
6,556
-16,199
| -71% | -$904K |
|
|
GHL
645
DELISTED
Greenhill & Co., Inc.
GHL
| $337K | ﹤0.01% |
11,831
+6,231
| +111% | +$229K |
|
646
Booking.com
BKNG
$149B
| $336K | ﹤0.01% |
6,800
-35,775
| -84% | -$1.78M |
|
|
SGI
647
Somnigroup International
SGI
$13.7B
| $336K | ﹤0.01% |
+18,824
| New | +$346K |
|
648
Duke Energy
DUK
$97.8B
| $335K | ﹤0.01% |
+4,651
| New | +$337K |
|
|
CELG
649
DELISTED
Celgene Corp
CELG
| $335K | ﹤0.01% |
3,100
+652
| +27% | +$80.9K |
|
650
L3Harris
LHX
$51.6B
| $331K | ﹤0.01% |
4,525
+125
| +3% | +$9.78K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.